Dr. Scott R. Silva
Claim this profileThe James Graham Brown Cancer Center at University of Louisville
Studies Prostate Cancer
Studies Adenocarcinoma
3 reported clinical trials
18 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
synaptophysin positive
chromogranin positive
2Adenocarcinoma
Affiliated Hospitals
Clinical Trials Scott R. Silva is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Focused Radiation vs Systemic Therapy
for Kidney Cancer
This phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer that has spread from where it first started (primary site) to a limited (2-5) number of places in the body (metastatic). Study doctors want to find out if this approach is better or worse than the usual approach for metastatic kidney cancer. The usual approach is defined as the care most people get for metastatic kidney cancer which includes systemic therapy such as immunotherapy (given through the veins) and/or small molecular inhibitor (tablets taken by mouth). Radiotherapy uses high energy x-rays to kill cancer cells and shrink tumors. SAbR uses special equipment to position a patient and deliver radiation to tumors with high precision. Giving SAbR prior to systemic therapy may kill more tumor cells than the usual approach, which is systemic therapy alone.
Recruiting2 awards Phase 319 criteria
More about Scott R. Silva
Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Scott R. Silva has experience with
- Intensity-Modulated Radiation Therapy (IMRT)
- Stereotactic Body Radiation Therapy (SBRT)
- Triptorelin
- Abiraterone
- Bicalutamide
- Degarelix
Breakdown of trials Scott R. Silva has run
Prostate Cancer
Adenocarcinoma
Low Testosterone
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott R. Silva specialize in?
Scott R. Silva focuses on Prostate Cancer and Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Scott R. Silva currently recruiting for clinical trials?
Yes, Scott R. Silva is currently recruiting for 2 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Scott R. Silva has studied deeply?
Yes, Scott R. Silva has studied treatments such as Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), Triptorelin.
What is the best way to schedule an appointment with Scott R. Silva?
Apply for one of the trials that Scott R. Silva is conducting.
What is the office address of Scott R. Silva?
The office of Scott R. Silva is located at: The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky 40202 United States. This is the address for their practice at the The James Graham Brown Cancer Center at University of Louisville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.